ID   L5178Y VDSR
AC   CVCL_AZ80
SY   L5178Y VDS-resistant
DR   Wikidata; Q54901044
RX   PubMed=7105380;
CC   Selected for resistance to: ChEBI; CHEBI_36373; Vindesine.
CC   Transformant: ChEBI; CHEBI_34342; 3-methylcholanthrene (3-MC; 20-methylcholanthrene; 20-MC; MCA).
CC   Derived from site: In situ; Thymus; UBERON=UBERON_0002370.
CC   Cell type: T-cell; CL=CL_0000084.
CC   Breed/subspecies: DBA/2.
DI   NCIt; C134997; Mouse thymic lymphoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2097 ! L-5178-Y
SX   Female
AG   8M
CA   Cancer cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 7
//
RX   PubMed=7105380; DOI=10.1007/BF00255477;
RA   Hill B.T., Whelan R.D.H.;
RT   "Establishment of vincristine-resistant and vindesine-resistant lines
RT   of murine lymphoblasts in vitro and characterisation of their patterns
RT   of cross-resistance and drug sensitivities.";
RL   Cancer Chemother. Pharmacol. 8:163-169(1982).
//